ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide Based Gastrointestinal Disorders Therapeutics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-25B16092
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Peptide Based Gastrointestinal Disorders Therapeutics Global Market Insights and Sales Trends 2024
BUY CHAPTERS

Global Peptide Based Gastrointestinal Disorders Therapeutics Market Research Report 2025

Code: QYRE-Auto-25B16092
Report
September 2025
Pages:62
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda
Ironwood Pharmaceuticals
Astellas Pharma
Allergan plc
Takeda Pharmaceutical

Peptide Based Gastrointestinal Disorders Therapeutics Market

The global market for Peptide Based Gastrointestinal Disorders Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.
North American market for Peptide Based Gastrointestinal Disorders Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peptide Based Gastrointestinal Disorders Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Peptide Based Gastrointestinal Disorders Therapeutics in Hospital Pharmacies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Peptide Based Gastrointestinal Disorders Therapeutics include Takeda, Ironwood Pharmaceuticals, Astellas Pharma, Allergan, Takeda Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide Based Gastrointestinal Disorders Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Based Gastrointestinal Disorders Therapeutics.
The Peptide Based Gastrointestinal Disorders Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Based Gastrointestinal Disorders Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Based Gastrointestinal Disorders Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peptide Based Gastrointestinal Disorders Therapeutics Market Report

Report Metric Details
Report Name Peptide Based Gastrointestinal Disorders Therapeutics Market
Segment by Type
  • Teduglutide
  • Linaclotide
  • Others
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, Ironwood Pharmaceuticals, Astellas Pharma, Allergan, Takeda Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Peptide Based Gastrointestinal Disorders Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Peptide Based Gastrointestinal Disorders Therapeutics Market report?

Ans: The main players in the Peptide Based Gastrointestinal Disorders Therapeutics Market are Takeda, Ironwood Pharmaceuticals, Astellas Pharma, Allergan, Takeda Pharmaceutical

What are the Application segmentation covered in the Peptide Based Gastrointestinal Disorders Therapeutics Market report?

Ans: The Applications covered in the Peptide Based Gastrointestinal Disorders Therapeutics Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Peptide Based Gastrointestinal Disorders Therapeutics Market report?

Ans: The Types covered in the Peptide Based Gastrointestinal Disorders Therapeutics Market report are Teduglutide, Linaclotide, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Teduglutide
1.2.3 Linaclotide
1.2.4 Others
1.3 Market by Application
1.3.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Perspective (2020-2031)
2.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Growth Trends by Region
2.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Peptide Based Gastrointestinal Disorders Therapeutics Market Dynamics
2.3.1 Peptide Based Gastrointestinal Disorders Therapeutics Industry Trends
2.3.2 Peptide Based Gastrointestinal Disorders Therapeutics Market Drivers
2.3.3 Peptide Based Gastrointestinal Disorders Therapeutics Market Challenges
2.3.4 Peptide Based Gastrointestinal Disorders Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue
3.1.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide Based Gastrointestinal Disorders Therapeutics Revenue
3.4 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio
3.4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2024
3.5 Global Key Players of Peptide Based Gastrointestinal Disorders Therapeutics Head office and Area Served
3.6 Global Key Players of Peptide Based Gastrointestinal Disorders Therapeutics, Product and Application
3.7 Global Key Players of Peptide Based Gastrointestinal Disorders Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Type
4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2026-2031)
5 Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Application
5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2020-2031)
6.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2020-2025)
6.4 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2020-2031)
7.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2020-2025)
7.4 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2020-2031)
9.2 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.1.4 Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025)
11.1.5 Takeda Recent Development
11.2 Ironwood Pharmaceuticals
11.2.1 Ironwood Pharmaceuticals Company Details
11.2.2 Ironwood Pharmaceuticals Business Overview
11.2.3 Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.2.4 Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025)
11.2.5 Ironwood Pharmaceuticals Recent Development
11.3 Astellas Pharma
11.3.1 Astellas Pharma Company Details
11.3.2 Astellas Pharma Business Overview
11.3.3 Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.3.4 Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025)
11.3.5 Astellas Pharma Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.4.4 Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025)
11.4.5 Allergan Recent Development
11.5 Takeda Pharmaceutical
11.5.1 Takeda Pharmaceutical Company Details
11.5.2 Takeda Pharmaceutical Business Overview
11.5.3 Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.5.4 Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025)
11.5.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Takeda
Ironwood Pharmaceuticals
Astellas Pharma
Allergan plc
Takeda Pharmaceutical
List of Tables
 Table 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Teduglutide
 Table 3. Key Players of Linaclotide
 Table 4. Key Players of Others
 Table 5. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2020-2025)
 Table 9. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2026-2031)
 Table 11. Peptide Based Gastrointestinal Disorders Therapeutics Market Trends
 Table 12. Peptide Based Gastrointestinal Disorders Therapeutics Market Drivers
 Table 13. Peptide Based Gastrointestinal Disorders Therapeutics Market Challenges
 Table 14. Peptide Based Gastrointestinal Disorders Therapeutics Market Restraints
 Table 15. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players (2020-2025)
 Table 17. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2024)
 Table 18. Ranking of Global Top Peptide Based Gastrointestinal Disorders Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Peptide Based Gastrointestinal Disorders Therapeutics, Headquarters and Area Served
 Table 21. Global Key Players of Peptide Based Gastrointestinal Disorders Therapeutics, Product and Application
 Table 22. Global Key Players of Peptide Based Gastrointestinal Disorders Therapeutics, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2020-2025)
 Table 26. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2026-2031)
 Table 28. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Application (2020-2025)
 Table 30. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Application (2026-2031)
 Table 32. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Takeda Company Details
 Table 48. Takeda Business Overview
 Table 49. Takeda Peptide Based Gastrointestinal Disorders Therapeutics Product
 Table 50. Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 51. Takeda Recent Development
 Table 52. Ironwood Pharmaceuticals Company Details
 Table 53. Ironwood Pharmaceuticals Business Overview
 Table 54. Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Product
 Table 55. Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 56. Ironwood Pharmaceuticals Recent Development
 Table 57. Astellas Pharma Company Details
 Table 58. Astellas Pharma Business Overview
 Table 59. Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Product
 Table 60. Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 61. Astellas Pharma Recent Development
 Table 62. Allergan Company Details
 Table 63. Allergan Business Overview
 Table 64. Allergan Peptide Based Gastrointestinal Disorders Therapeutics Product
 Table 65. Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 66. Allergan Recent Development
 Table 67. Takeda Pharmaceutical Company Details
 Table 68. Takeda Pharmaceutical Business Overview
 Table 69. Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Product
 Table 70. Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 71. Takeda Pharmaceutical Recent Development
 Table 72. Research Programs/Design for This Report
 Table 73. Key Data Information from Secondary Sources
 Table 74. Key Data Information from Primary Sources
 Table 75. Authors List of This Report


List of Figures
 Figure 1. Peptide Based Gastrointestinal Disorders Therapeutics Picture
 Figure 2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Teduglutide Features
 Figure 5. Linaclotide Features
 Figure 6. Others Features
 Figure 7. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Pharmacies Case Studies
 Figure 10. Retail Pharmacies Case Studies
 Figure 11. Online Pharmacies Case Studies
 Figure 12. Peptide Based Gastrointestinal Disorders Therapeutics Report Years Considered
 Figure 13. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region: 2024 VS 2031
 Figure 16. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players in 2024
 Figure 17. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2024
 Figure 19. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2020-2031)
 Figure 21. United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2020-2031)
 Figure 25. Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2020-2031)
 Figure 33. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2020-2031)
 Figure 41. Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2020-2031)
 Figure 45. Turkey Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Takeda Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025)
 Figure 49. Ironwood Pharmaceuticals Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025)
 Figure 50. Astellas Pharma Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025)
 Figure 51. Allergan Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025)
 Figure 52. Takeda Pharmaceutical Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2020-2025)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Gastrointestinal Therapeutics Market Research Report 2024
Global Gastrointestinal Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Gastrointestinal Drugs Market Research Report 2025
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prescription Gastrointestinal Drugs Market Research Report 2024
Gastrointestinal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastroenterology Devices Market Insights Forecast to 2030
Gastrointestinal Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digestive Drugs Market Insights Forecast to 2030
Global Gastrointestinal Cancer Devices Market Research Report 2024
Global Digestive Remedies Market Research Report 2024
Global OTC Gastrointestinal Products Market Research Report 2024
Gastro Esophageal Reflux Disease Drug and Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastrointestinal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastrointestinal OTC Drugs Market Research Report 2024
Global Gastrointestinal Stents Market Research Report 2024
Global OTC Digestives and Intestinal Remedies Market Research Report 2024
Global Bacterial Enteric Disease Testing Market Research Report 2024
Global Gastrointestinal Bleeding Treatment Market Insights Forecast to 2030
Global Gastrointestinal Rare Diseases Treatment Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions